Optimal range of plasma concentration of true 1-84 parathyroid hormone in patients on maintenance dialysis [8]

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 4, 2001, Pages 1840-1841

  Fournier, A ^a   Cohen Solal, M E ^a   Oprisiu, R ^a   Mazouz, H ^a   Morinire, P ^a   Choukroun, G ^a   Bouillon, R ^b  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; PARATHYROID HORMONE;

BONE REMODELING; HEMODIALYSIS; HEMODIALYSIS PATIENT; HORMONE DETERMINATION; HUMAN; IMMUNORADIOMETRIC ASSAY; KIDNEY FAILURE; LETTER; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL;

HUMANS; IMMUNORADIOMETRIC ASSAY; OSMOLAR CONCENTRATION; PARATHYROID HORMONE; RENAL DIALYSIS;

EID: 0035034715     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.4.1840     Document Type: Letter

References (14)

1. A novel immunoradiometric assay detects full-length human PTH but not aminoterminally truncated fragment: Implication for PTH measurements in renal failure
2. A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples
3. Immunoradiometric assay of parathyrin with polyclonal and monoclonal region-specific antibodies
4. Comparison of intact, midregion, and carboxy terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialysed patients
5. Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia
6. Relationship between intact PTH (1-84) parathyroid hormone and bone histomorphometry parameters in dialysis patients without aluminum toxicity
7. Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: Importance in the interpretation of PTH values
8. Parathyroid hormone biosynthesis and metabolism
9. A novel mechanism for skeletal resistance in uremia
10. Adynamic bone disease in patients with uremia
11. Bone cell response in uremia
12. Effect of alfacalcidol on natural course of bone disease in mild to moderate renal failure
13. Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy
14. Skeletal resistance to parathyroid hormone in renal failure: Study in 105 human subjects